94 related articles for article (PubMed ID: 9469624)
1. Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis.
Tamao Y; Kikumoto R
Semin Thromb Hemost; 1997; 23(6):523-30. PubMed ID: 9469624
[TBL] [Abstract][Full Text] [Related]
2. Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
Kawai H; Yuki S; Sugimoto J; Tamao Y
J Pharmacol Exp Ther; 1996 Aug; 278(2):780-5. PubMed ID: 8768731
[TBL] [Abstract][Full Text] [Related]
3. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis.
Kobayashi S; Tazaki Y
Semin Thromb Hemost; 1997; 23(6):531-4. PubMed ID: 9469625
[TBL] [Abstract][Full Text] [Related]
4. Effect of argatroban on microthrombi formation and brain damage in the rat middle cerebral artery thrombosis model.
Kawai H; Umemura K; Nakashima M
Jpn J Pharmacol; 1995 Oct; 69(2):143-8. PubMed ID: 8569051
[TBL] [Abstract][Full Text] [Related]
5. A specific thrombin inhibitor (argatroban) ameliorated cerebral blood flow in the patients with acute cerebral infarction.
Maruki Y; Onoda A; Matsuzaki M; Narabayashi Y; Sawada M; Shimazu K
Keio J Med; 2000 Feb; 49 Suppl 1():A138-40. PubMed ID: 10750365
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat.
Umemura K; Kawai H; Ishihara H; Nakashima M
Jpn J Pharmacol; 1995 Mar; 67(3):253-8. PubMed ID: 7630043
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation.
Sasaki Y; Morii S; Yamashita T; Yamamoto J
Haemostasis; 1993; 23(2):104-11. PubMed ID: 8365687
[TBL] [Abstract][Full Text] [Related]
8. The regional cerebral blood flow amelioration of argatroban in the acute stage of cerebral thrombosis.
Yamashita T; Hayashida O; Nagamitsu T; Nagatsuna T; Wakuta Y; Fudaba H
Keio J Med; 2000 Feb; 49 Suppl 1():A141-4. PubMed ID: 10750366
[TBL] [Abstract][Full Text] [Related]
9. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
Matsuo T; Koide M; Kario K
Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.
Urabe T; Tanaka R; Noda K; Mizuno Y
J Thromb Thrombolysis; 2002 Jun; 13(3):155-60. PubMed ID: 12355032
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of argatroban on ellagic acid-induced cerebral thromboembolism in rats.
Hara T; Iwamoto M; Ishihara M; Tomikawa M
Haemostasis; 1994; 24(6):351-7. PubMed ID: 7843647
[TBL] [Abstract][Full Text] [Related]
12. [Argatroban, a selective thrombin inhibitor, for anticoagulant therapy during and following vascular surgery].
Fuji H; Kurasako N; Takebayashi T; Tanaka T; Sakano S; Kosogabe Y; Mano M; Nagase H
Masui; 1996 Oct; 45(10):1289-92. PubMed ID: 8937032
[TBL] [Abstract][Full Text] [Related]
13. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
Imura Y; Stassen JM; Collen D
J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
[TBL] [Abstract][Full Text] [Related]
14. Development of argatroban as an anticoagulant and antithrombin agent in Japan.
Ikoma H
Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():23-8. PubMed ID: 12811008
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of cerebral infarction in the acute stage with synthetic antithrombin MD-805: a multicenter clinical study].
Yonekawa Y; Handa H; Okamoto S; Kamijo Y; Oda Y; Ishikawa J; Tsuda H; Shimizu Y; Satoh M; Yamagami T
Nihon Geka Hokan; 1986 Sep; 55(5):711-26. PubMed ID: 3579459
[No Abstract] [Full Text] [Related]
16. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
[TBL] [Abstract][Full Text] [Related]
17. Argatroban in thrombotic stroke.
LaMonte MP
Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():39-45. PubMed ID: 12811011
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-controlling medicines: introduction.
Okamoto S; Hijikata-Okunomiya A; Wanaka K; Okada Y; Okamoto U
Semin Thromb Hemost; 1997; 23(6):493-501. PubMed ID: 9469621
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
